Alivus Life Sciences Ltd

Alivus Life Sciences (formerly Glenmark) to Review Q3 & 9M FY26 Results 📅📊

- Board meeting on January 22, 2026 to approve Unaudited Financial Results for quarter and nine months ended December 31, 2025.

- Trading Window closure from December 31, 2025 to January 24, 2026 (both days inclusive) for designated persons.

- Company now operates as Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited).